Cochrane Abstracts
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease‐modifying anti‐rheumatic drugs: a systematic review and network meta‐analysis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Biologics or Tofacitinib for Rheumatoid Arthritis in Incomplete Responders to Methotrexate or Other Traditional Disease‐modifying Anti‐rheumatic Drugs: a Systematic Review and Network Meta‐analysis." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437293/1/Biologics_or_tofacitinib_for_rheumatoid_arthritis_in_incomplete_responders_to_methotrexate_or_other_traditional_disease‐modifying_anti‐rheumatic_drugs:_a_systematic_review_and_network_meta‐analysis.
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease‐modifying anti‐rheumatic drugs: a systematic review and network meta‐analysis. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437293/1/Biologics_or_tofacitinib_for_rheumatoid_arthritis_in_incomplete_responders_to_methotrexate_or_other_traditional_disease‐modifying_anti‐rheumatic_drugs:_a_systematic_review_and_network_meta‐analysis. Accessed December 12, 2024.
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease‐modifying anti‐rheumatic drugs: a systematic review and network meta‐analysis. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437293/1/Biologics_or_tofacitinib_for_rheumatoid_arthritis_in_incomplete_responders_to_methotrexate_or_other_traditional_disease‐modifying_anti‐rheumatic_drugs:_a_systematic_review_and_network_meta‐analysis
Biologics or Tofacitinib for Rheumatoid Arthritis in Incomplete Responders to Methotrexate or Other Traditional Disease‐modifying Anti‐rheumatic Drugs: a Systematic Review and Network Meta‐analysis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437293/1/Biologics_or_tofacitinib_for_rheumatoid_arthritis_in_incomplete_responders_to_methotrexate_or_other_traditional_disease‐modifying_anti‐rheumatic_drugs:_a_systematic_review_and_network_meta‐analysis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease‐modifying anti‐rheumatic drugs: a systematic review and network meta‐analysis
ID - 437293
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437293/1/Biologics_or_tofacitinib_for_rheumatoid_arthritis_in_incomplete_responders_to_methotrexate_or_other_traditional_disease‐modifying_anti‐rheumatic_drugs:_a_systematic_review_and_network_meta‐analysis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
